Skip to main content
Inify Laboratories AB logo

Inify Laboratories AB — Investor Relations & Filings

Ticker · INIFY ISIN · SE0017486103 LEI · 549300306YYJ3BX3VB98 ST Human health and social work activities
Open in API
Filings indexed 341 across all filing types
Latest filing 2023-04-26 Interim / Quarterly Rep…
Country SE Sweden
Listing ST INIFY

About Inify Laboratories AB

https://www.inify.com/

Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. The company utilizes a fully digital, standardized, and AI-supported workflow for histopathology analysis. This integrated service model is designed to optimize the entire diagnostic process, from sample receipt to final report, ensuring high quality and significantly reduced turnaround times for clinical partners. Initially focused on prostate cancer, the company has expanded its diagnostic capabilities to include other areas such as gastroenterology. By streamlining the clinical pathway, Inify Laboratories enables healthcare providers to receive faster results, which facilitates earlier patient follow-up and treatment planning.

Recent filings

Filing Released Lang Actions
Inify Laboratories - Strong market interest and launch on track
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the first quarter 2023' and contains comprehensive financial data, including key figures, operating results, cash flow, and balance sheet information for the specified period. It is a substantive financial report rather than an announcement or a certification, fitting the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-04-26 English
Inify Laboratories - Strong market interest and launch on track
Regulatory Filings Classification · 90% confidence The document is a short press release dated April 26, 2023, providing an operational update on the progress of building and launching a new laboratory service (Inify Laboratories). It discusses market interest, installation progress, and a new logistics agreement. It does not contain comprehensive financial statements (ruling out 10-K or IR), nor is it a transcript (CT) or a formal board change announcement (MANG). Since it is a general operational update that doesn't fit the specific categories like DIV, CAP, or DIRS, and it is a direct announcement rather than a notice about another report, it best fits the general 'Regulatory Filings' category (RNS) as a miscellaneous corporate announcement, although it reads like a general press release. Given the context of financial filings, RNS serves as the appropriate fallback for non-standard, non-financial updates.
2023-04-26 English
Inify Laboratories - kallelse till årsstämma den 16 maj 2023
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Inify Laboratories AB (publ)" which translates to 'Notice of Annual General Meeting in Inify Laboratories AB (publ)'. The text details the date, time, location, registration requirements, and the proposed agenda for the meeting, including items like electing the board, approving the annual report, and deciding on remuneration. This content is characteristic of a formal notice calling shareholders to an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document length (9023 chars) is substantial, indicating it is the primary notice document, not just a brief announcement of publication (RPA/RNS).
2023-04-12 Swedish
Inify Laboratories - notice of Annual General Meeting on May 16, 2023
AGM Information Classification · 99% confidence The document is explicitly titled 'Notice to Annual General Meeting in Inify Laboratories AB (publ)' and details the date, time, location, agenda items (including election of chairman, approval of accounts, remuneration, and board elections), and procedures for shareholders to attend and vote. This content directly corresponds to the materials distributed to shareholders in advance of the Annual General Meeting (AGM). Although it contains elements that might be found in an Annual Report (like the presentation of annual accounts), the primary function and title indicate it is the formal notice/invitation for the AGM. Therefore, the most appropriate classification is AGM Information (AGM-R).
2023-04-12 English
Inify Laboratories - Årsredovisning 2022
Annual Report Classification · 100% confidence The document is explicitly titled 'Inify Laboratories Årsredovisning 2022' (Annual Report 2022). It contains a comprehensive overview of the company, including the CEO's statement, market analysis, business operations, sustainability, corporate governance, and financial statements (noted in the table of contents on page 1). As it is the full annual report for the fiscal year 2022, it fits the definition of a 10-K/Annual Report. FY 2022
2023-04-12 Norwegian
Inify Laboratories - Annual Report 2022
Annual Report Classification · 100% confidence The document is explicitly titled 'Inify Laboratories Annual Report 2022'. It contains a table of contents listing sections such as 'Corporate Governance Report', 'Administration Report', 'Financial statements', and 'Auditor's Report'. The content provides a comprehensive overview of the company's operations, market drivers, and financial performance for the fiscal year 2022. It meets the criteria for an Annual Report (10-K) as it is the official yearly report covering company activity and financial performance. FY 2022
2023-04-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.